Bios Capital Management, LP Ocuphire Pharma, Inc. Transaction History
Bios Capital Management, LP
- $95.9 Billion
- Q4 2024
A detailed history of Bios Capital Management, LP transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Bios Capital Management, LP holds 2,480,983 shares of OCUP stock, worth $2.43 Million. This represents 3.08% of its overall portfolio holdings.
Number of Shares
2,480,983Holding current value
$2.43 Million% of portfolio
3.08%Shares
2 transactions
Others Institutions Holding OCUP
# of Institutions
47Shares Held
5.21MCall Options Held
12.6KPut Options Held
1.8K-
Vanguard Group Inc Valley Forge, PA992KShares$972,3560.0% of portfolio
-
Geode Capital Management, LLC Boston, MA314KShares$307,7040.0% of portfolio
-
Voss Capital, LLC Houston, TX191KShares$187,1380.02% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il176KShares$172,2570.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny146KShares$142,5980.0% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $20.2M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...